EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In skeletal muscle and neural crest cells, SMCHD1 regulates biological pathways relevant for Bosma syndrome and facioscapulohumeral dystrophy phenotype

Camille Laberthonnière, Mégane Delourme, Raphaël Chevalier, Camille Dion, Benjamin Ganne, David Hirst iD, Leslie Caron, Pierre Perrin, José Adélaïde, Max Chaffanet, Shifeng Xue, Karine Nguyen und 5 weitere

Nucleic Acids Research · 2023

DOI: 10.1093/nar/gkad523 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2023. Verfasst von Camille Laberthonnière und 16 weiteren Autor:innen. Beteiligte Einrichtung: Aix Marseille Univ, INSERM, Marseille Medical Genetics, Marseille 13005, France. Hauptthemen laut MEDLINE: Microphthalmos, Muscular Dystrophy, Facioscapulohumeral. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Association Française contre les Myopathies, Fondation Maladies Rares, Agence Nationale pour la Recherche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Many genetic syndromes are linked to mutations in genes encoding factors that guide chromatin organization. Among them, several distinct rare genetic diseases are linked to mutations in SMCHD1 that encodes the structural maintenance of chromosomes flexible hinge domain containing 1 chromatin-associated factor. In humans, its function as well as the impact of its mutations remains poorly defined. To fill this gap, we determined the episignature associated with heterozygous SMCHD1 variants in primary cells and cell lineages derived from induced pluripotent stem cells for Bosma arhinia and microphthalmia syndrome (BAMS) and type 2 facioscapulohumeral dystrophy (FSHD2). In human tissues, SMCHD1 regulates the distribution of methylated CpGs, H3K27 trimethylation and CTCF at repressed chromatin but also at euchromatin. Based on the exploration of tissues affected either in FSHD or in BAMS, i.e. skeletal muscle fibers and neural crest stem cells, respectively, our results emphasize multiple functions for SMCHD1, in chromatin compaction, chromatin insulation and gene regulation with variable targets or phenotypical outcomes. We concluded that in rare genetic diseases, SMCHD1 variants impact gene expression in two ways: (i) by changing the chromatin context at a number of euchromatin loci or (ii) by directly regulating some loci encoding master transcription factors required for cell fate determination and tissue differentiation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrophthalmosMuscular Dystrophy, FacioscapulohumeralNoseChoanal AtresiaMuscle, SkeletalPhenotypeHumansNeural CrestChromosomal Proteins, Non-HistoneChromatinEuchromatin

Substanzen

EuchromatinChromosomal Proteins, Non-HistoneChromatinSMCHD1 protein, human

Autor:innen und Institutionen

  • Aix Marseille Univ, INSERM, Marseille Medical Genetics, Marseille 13005, France.
  • Aix Marseille Univ, INSERM, CNRS, Institut Paoli Calmette, Centre de Recherche en Cancérologie de Marseille, Laboratory of predictive Oncology, Marseille 13009, France.
  • Department of Biological Sciences, National University of Singapore, Singapore 117558, Singapore.
  • Genome Institute of Singapore, A*STAR, Singapore, Singapore.
  • Département de Génétique Médicale, AP-HM, Hôpital d'enfants de la Timone, Marseille 13005, France.
  • Department of Medical Genetics, Koç University, School of Medicine, Istanbul, Turkey.

ORCID-Profile: David Hirst, Bruno Reversade, Frédérique Magdinier

Förderung

  • Association Française contre les Myopathies
  • Fondation Maladies Rares
  • Agence Nationale pour la Recherche
  • Ministry of Education, France
  • FSH Society
  • Aix-Marseille University
  • Agency for Science, Technology and Research
  • Ministry of Education

Zitieren

APA

Laberthonnière, C., Delourme, M., Chevalier, R., Dion, C., Ganne, B., Hirst, D., Caron, L., Perrin, P., Adélaïde, J., Chaffanet, M., Xue, S., Nguyen, K., Reversade, B., Déjardin, J., Baudot, A., Robin, J. D., & Magdinier, F. (2023). In skeletal muscle and neural crest cells, SMCHD1 regulates biological pathways relevant for Bosma syndrome and facioscapulohumeral dystrophy phenotype. Nucleic Acids Research. https://doi.org/10.1093/nar/gkad523

Vancouver

Laberthonnière C, Delourme M, Chevalier R, Dion C, Ganne B, Hirst D, et al. In skeletal muscle and neural crest cells, SMCHD1 regulates biological pathways relevant for Bosma syndrome and facioscapulohumeral dystrophy phenotype. Nucleic Acids Research. 2023. doi:10.1093/nar/gkad523

BibTeX
@article{Laberthonnire2023,
  author = {Laberthonnière, Camille and Delourme, Mégane and Chevalier, Raphaël and Dion, Camille and Ganne, Benjamin and Hirst, David and Caron, Leslie and Perrin, Pierre and Adélaïde, José and Chaffanet, Max and Xue, Shifeng and Nguyen, Karine and Reversade, Bruno and Déjardin, Jérôme and Baudot, Anaïs and Robin, Jérôme D and Magdinier, Frédérique},
  title = {In skeletal muscle and neural crest cells, SMCHD1 regulates biological pathways relevant for Bosma syndrome and facioscapulohumeral dystrophy phenotype},
  journal = {Nucleic Acids Research},
  year = {2023},
  doi = {10.1093/nar/gkad523}
}
Kostenlos starten →